Utilization and safety of sodium hyaluronate- Carboxymethylcellulose adhesion barrier

Diseases of the Colon and Rectum

Volumn 56, Issue 10, 2013, Pages 1174-1184

  Bashir, Shazia ^a   Ananth, Cande V ^a   Lewin, Sharyn N ^a,b   Burke, William M ^a   Lu, Yu Shiang ^a   Neugut, Alfred I ^a,b,c   Herzog, Thomas J ^a,c   Hershman, Dawn L ^a,b,c   Wright, Jason D ^a,c  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Department of Medicine   (United States)

^c Department of Medicine   (United States)

Author keywords

Adhesion; Colectomy.; Hyaluronate carboxymethylcellulose; Hyaluronic acid carboxymethyl cellulose membrane; Hysterectomy

Indexed keywords

CARBOXYMETHYLCELLULOSE; HYALURONIC ACID;

ABSCESS; ADHESION BARRIER; ADULT; ARTICLE; COHORT ANALYSIS; COLON RESECTION; COLORECTAL SURGERY; DRUG SAFETY; ENTEROPATHY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; ILEUS; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERITONITIS; POSTOPERATIVE COMPLICATION; PREDICTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGEON; WOUND COMPLICATION;

BIOCOMPATIBLE MATERIALS; CARBOXYMETHYLCELLULOSE SODIUM; COLECTOMY; FEMALE; HOSPITALS; HUMANS; HYALURONIC ACID; HYSTERECTOMY; LOGISTIC MODELS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE ADHESIONS;

EID: 84884498331     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31829ec889     Document Type: Article

References (37)

1. Kumar S, Wong PF, Leaper DJ. Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database Syst Rev. 2009:CD005080.
2. Stanciu D, Menzies D. The magnitude of adhesion-related problems. Colorectal Dis. 2007;9(suppl 2):35-38. (Pubitemid 47323716)
3. Menzies D. Peritoneal adhesions. Incidence, cause, and prevention. Surg Annu. 1992;24(pt 1):27-45.
4. Menzies D, Parker M, Hoare R, Knight A. Small bowel obstruction due to postoperative adhesions: treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl. 2001;83:40-46. (Pubitemid 32058620)
5. Parker MC, Wilson MS, van Goor H, et al. Adhesions and colorectal surgery: call for action. Colorectal Dis. 2007;9(suppl 2):66-72.
6. Metwally M, Watson A, Lilford R, Vandekerckhove P. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2006:CD001298.
7. diZerega GS. Contemporary adhesion prevention. Fertil Steril. 1994;61:219-235. (Pubitemid 24057251)
8. Ahmad G, Duffy JM, Farquhar C, et al. Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2008:CD000475.
9. Beck DE. Seprafilm review and meta-analysis. World J Surg. 2008;32:1883-1885.
10. Holmdahl L. A misleading meta-analysis of seprafilm. World J Surg. 2008;32:1888-1891.
11. Krill LS, Ueda SM, Gerardi M, Bristow RE. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers. Gynecol Oncol. 2011;120:220-223.
12. Leitao MM Jr, Byrum GV 3rd, Abu-Rustum NR, et al. Postoperative intra-abdominal collections using a sodium hyaluronatecarboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers. Gynecol Oncol. 2010;119: 208-211.
13. Leitao MM Jr, Natenzon A, Abu-Rustum NR, et al. Postoperative intra-abdominal collections using a sodium hyaluronatecarboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers. Gynecol Oncol. 2009;115:204-208.
14. Zeng Q, Yu Z, You J, Zhang Q. Efficacy and safety of Seprafilm for preventing postoperative abdominal adhesion: systematic review and meta-analysis. World J Surg. 2007;31:2125-2132.
15. Lagu T, Rothberg MB, Nathanson BH, Pekow PS, Steingrub JS, Lindenauer PK. The relationship between hospital spending and mortality in patients with sepsis. Arch Intern Med. 2011;171:292-299.
16. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349-361. (Pubitemid 41132339)
17. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303:2359-2367.
18. Logan AC, Yank V, Stafford RS. Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records. Ann Intern Med. 2011;154:516-522.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
20. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
21. Hollenbeck BK, Wei Y, Birkmeyer JD. Volume, process of care, and operative mortality for cystectomy for bladder cancer. Urology. 2007;69:871-875. (Pubitemid 46670225)
22. Birkmeyer JD, Sun Y, Wong SL, Stukel TA. Hospital volume and late survival after cancer surgery. Ann Surg. 2007;245:777-783. (Pubitemid 46684108)
23. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162:199-200. (Pubitemid 41373523)
24. Hemmila MR, Birkmeyer NJ, Arbabi S, Osborne NH, Wahl WL, Dimick JB. Introduction to propensity scores: a case study on the comparative effectiveness of laparoscopic vs open appendectomy. Arch Surg. 2010;145:939-945.
25. Dagostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
26. Stukel TA , Fisher ES, Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA. 2007;297:278-285. (Pubitemid 46143305)
27. Beck DE, Cohen Z, Fleshman JW, Kaufman HS, van Goor H, Wolff BG; Adhesion Study Group Steering Committee. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum. 2003;46:1310-1319. (Pubitemid 37267623)
28. Fazio VW, Cohen Z, Fleshman JW, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1-11. (Pubitemid 41830649)
29. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, doubleblind multicenter study. J Am Coll Surg. 1996;183:297-306.
30. Diamond MP. Reduction of de novo postsurgical adhesions by intraoperative precoating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertil Steril. 1998;69:1067-1074. (Pubitemid 28274895)
31. Tang CL, Jayne DG, Seow-Choen F, Ng YY, Eu KW, Mustapha N. A randomized controlled trial of 0.5% ferric hyaluronate gel (Intergel) in the prevention of adhesions following abdominal surgery. Ann Surg. 2006;243:449-455.
32. Wiseman DM. Possible Intergel Reaction Syndrome (pIRS). Ann Surg. 2006;244:630-632. (Pubitemid 44435781)
33. Tzianabos AO , Cisneros RL, Gershkovich J, et al. Effect of surgical adhesion reduction devices on the propagation of experimental intra-abdominal infection. Arch Surg. 1999;134:1254-1259.
34. Wiseman DM. Registries for anti-adhesion products? Fertil Steril. 2006;86:771; author reply 771-772. (Pubitemid 44307049)
35. Tyler JA, McDermott D, Levoyer T. Sterile intra-abdominal fluid collection associated with seprafilm use. Am Surg. 2008;74:1107-1110.
36. Cohen Z, Senagore AJ, Dayton MT, et al. Prevention of postoperative abdominal adhesions by a novel, glycerol/sodium hyaluronate/ carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study. Dis Colon Rectum. 2005;48:1130-1139. (Pubitemid 40897855)
37. Mohri Y, Kusunoki M. Efficacy and safety of seprafilm: systematic review and meta-analysis. World J Surg. 2008;32:1886-1887, 1890.